About DELPOR INC
Delpor is a clinical-stage biopharmaceutical company that utilizes innovative technologies to develop once-yearly therapies for chronic diseases, focusing on CNS conditions such as Schizophrenia, Opioid Use Disorder, Spasticity, Parkinson’s, Alzheimer’s, and MS.
Development of once-yearly therapies for chronic diseasesSustained release of drugs from a small, non-mechanical subcutaneous implant deviceDelivery of therapeutic agents within a predefined therapeutic window over several monthsZero-order release pharmacokinetics
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to DELPOR INC right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.